One Drop announced positive data from multiple studies evaluating the opinions of people with diabetes on continuous glucose monitoring.
New York-based One Drop presented new research about attitudes and adoption of continuous glucose monitors (CGMs) among people with type 2 diabetes at the American Diabetes Association (ADA) 82nd Scientific Sessions in New Orleans.
Get the full story at our sister site, Drug Delivery Business News.